TY - JOUR
KW - COVID-19
KW - Humans
KW - Opioid-Related Disorders/diagnosis
KW - Pandemics
KW - SARS-CoV-2
KW - Self Report
KW - Substance Abuse Detection
KW - United States
KW - Urinalysis
KW - buprenorphine
KW - opioid use disorder
KW - substance use
KW - urine drug screen
AU - U. G. Khatri
AU - S. V. Aronowitz
A1 - 
AD - National Clinician Scholars Program, University of Pennsylvania, Philadelphia, PA 19104, USA; Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA 19104, USA; Department of Emergency Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: utsha.khatri@pennmedicine.upenn.edu.; National Clinician Scholars Program, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: Shoshana.aronowitz@pennmedicine.upenn.edu.
BT - Journal of substance abuse treatment
C5 - Education & Workforce; Healthcare Disparities; HIT & Telehealth; Opioids & Substance Use
CY - United States
DO - 10.1016/j.jsat.2020.108258
JF - Journal of substance abuse treatment
LA - eng
M1 - Journal Article
PB - Elsevier Inc
PP - United States
PY - 2021
SN - 1873-6483; 0740-5472
SP - 108258
T1 - Considering the harms of our habits: The reflexive urine drug screen in opioid use disorder treatment
T2 - Journal of substance abuse treatment
TI - Considering the harms of our habits: The reflexive urine drug screen in opioid use disorder treatment
U1 - Education & Workforce; Healthcare Disparities; HIT & Telehealth; Opioids & Substance Use
U2 - 33358617
U3 - 10.1016/j.jsat.2020.108258
VL - 123
VO - 1873-6483; 0740-5472
Y1 - 2021
Y2 - Apr
ER -